AMN

Neurology·MeSH: Sialic Acid Storage Disease

7 drugs in development·5 companies·1 clinical trial

Drug Pipeline by Phase

Approved(2)

Drug	Company
simpligraft	Xtant Medical Holdings, Inc. (XTNT)
simplimax	Xtant Medical Holdings, Inc. (XTNT)

Phase 2(1)

Drug	Company
melt-210	HARROW, INC. (IMMY)

Phase 1(1)

Drug	Company
VK0214	Viking Therapeutics, Inc. (VKTX)

Preclinical(1)

Drug	Company
rpi-78m	NUTRA PHARMA CORP (NPHC)

N/A(2)

Drug	Company
ampicillin gentamicin	UNITED THERAPEUTICS Corp (UTHR)
Ampicillin gentamicin clindamycin	UNITED THERAPEUTICS Corp (UTHR)

BioSniper tracks 7 drugs in development for AMN across 5 companies.

There are 1 clinical trial targeting AMN tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.